• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising
New Products
Avatrombopag Maleate
BioHub® Magnetic Separator
Avatrombopag
Ursodeoxycholic acid
Troxerutin
CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

US FDA completes inspection of Lupin’s Pithampur Unit-2 (Indore) facility

expressbpdFebruary 12, 2019

Tag: lupin , Inspection , FDA

US FDA completes inspection of Lupin’s Pithampur Unit-2 (Indore) facility.

US FDA completes inspection of Lupin’s Pithampur Unit-2 (Indore) facility

Lupin announced the completion of the United States Food and Drug Administration (US FDA) inspection carried out at its Pithampur Unit -2 (Indore) facility. The inspection was carried out between January 14 and January 25, 2019.

The inspection at Pithampur Unit-2 (Indore) closed with six observations. The company is confident ofaddressing the observations satisfactorily.

Register as Visitor to CPhI China 2019!

Register as Visitor to CPhI China 2019!

-----------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.

 

Previous:Aurobindo acquires Apotex’s operations in five European countries

Next:WuXi Biologics and Amicus Sign Exclusive Manufacturing Partnership

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

US FDA completes inspection of Lupin’s Pithampur Unit-2 (Indore) facility | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

Mesnaum (FDA)

Mesnaum (FDA)
Cyclosporin A (FDA)

Cyclosporin A (FDA)
Thiophosphoramide (FDA)

Thiophosphoramide (FDA)
Vecuronium Bromide(FDA)

Vecuronium Bromide(FDA)
Automatic Inspection Machine LFIM-48

Automatic Inspection Machine LFIM-48
Deoxycyline (FDA)

Deoxycyline (FDA)
Auto Capsule Inspection Machine Model CI

Auto Capsule Inspection Machine Model CI
JAZ800/20 Ampoule Automatic Impurity Inspection Machine

JAZ800/20 Ampoule Automatic Impurity Inspection Machine
Vecuronium (FDA)

Vecuronium (FDA)
Ramantadine( FDA)

Ramantadine( FDA)

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service